ArticleMaterials (Basel, Switzerland)2025
Study on Performance and Aging Mechanism of Rubber-Modified Asphalt Under Variable-Intensity UV Aging.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reliability-Based Recycling of Reclaimed Asphalt Pavement Using a t-Distribution Guarantee Rate Method and a Ternary Composite Rejuvenation System.Materials (Basel, Switzerland) · 2026Article
- Statistical optimization of crumb rubber modified bitumen performance through material blending analysis.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Prolonged ultraviolet (UV) exposure accelerates aging and degradation, while conventional constant-intensity UV simulations do not reflect the variable nature of outdoor radiation. Aging duration and film thickness are both key factors affecting Rubber-Modified Asphalt (RMA), but how their combination influences RMA remains unclear. To address this limitation, this research employed accelerated aging experiments under variable-intensity UV radiation to investigate the performance and aging mechanism of RMA across different aging durations and asphalt film thicknesses. Rheological properties were analyzed through rheological tests, and the UV aging mechanisms of RMA were revealed using FTIR and SEM. The results revealed that crumb rubber improved RMA's UV aging resistance, including high-temperature performance, fatigue life, and low-temperature cracking resistance. Aging effects were more influenced in RMA with thinner films under prolonged UV exposure. After nine cycles of ultraviolet aging, the rutting resistance, elastic recovery, fatigue life, and low-temperature cracking resistance of RMA with a 1 mm film thickness were 1.33, 1.11, 0.54, and 0.67 times, respectively, those of RMA with a 2 mm film thickness subjected to three UV aging cycles. RMA demonstrated comparable high-temperature performance and elastic recovery under UV aging conditions corresponding to a 1.5 mm film thickness aged for three cycles and a 2.0 mm film thickness aged for six cycles, as well as a 1.0 mm film thickness aged for six cycles and a 1.5 mm film thickness aged for nine cycles. FTIR showed that the increased activity of C=C and C-H under photo-oxidative aging caused a greater impact on the carbonyl groups than the sulfoxide groups. Under high-intensity UV radiation, RMA with thinner films exhibited greater rubber powder detachment, increased surface oxidation, and a substantial widening of cracks. The rubber powder absorbed UV radiation, enhancing the stability of RMA. The maximum crack width of the 1 mm NA was twice that of RMA. These provided insight into the microstructural pattern of cracking resistance degradation caused by aging. This research provides theoretical support for the optimization of the anti-aging performance of RMA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.